S17 and S18, respectively) showed potential trends toward increasing spike-specific CD8+ T cell degranulation response (CD107a+), higher frequencies of spike-specific CD4+ IL-2+ T cells, and higher frequencies of spike-specific CD4+ IFN-γ+ T cells in COVID-19 convalescent patients (P = 0.036). This evidence concerns the gene LAMP1 and COVID-19.